Internal Medicine, Hematology & Oncology · Atlanta, GA
NPI
1740496850
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1800 Howell Mill Rd NW Ste 800
Atlanta, GA, 30318
Phone (404) 350-9853
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
69,360 services
Medicare patients, 2024
460
Average age 74
Drug cost, 2024
$4.8M
1,632 prescriptions
Company payments, 2025
$11K
From 42 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajni Sinha was code J0897 (injection, denosumab, 1 mg), 4,260 times for 15 patients. In total Rajni Sinha billed 69,360 services in 122 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,260 | 15 | $19.63 | $84K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,800 | 17 | $15.06 | $27K |
| 85025 Blood Count | Office | 622 | 270 | $7.60 | $4,729 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 498 | 17 | $0.09 | $42.68 |
| 99213 Office E&M - Established | Office | 424 | 281 | $60.90 | $26K |
| 99214 Office E&M - Established | Office | 337 | 160 | $85.60 | $29K |
| 96372 Injection Administration | Office | 161 | 47 | $10.07 | $1,621 |
| 96413 Chemotherapy Administration | Office | 159 | 43 | $92.77 | $15K |
| 96367 Intravenous Infusion, Hydration | Office | 101 | 23 | $20.31 | $2,051 |
| 99204 Office E&M - New | Office | 54 | 54 | $111.55 | $6,023 |
| 96361 Intravenous Infusion, Hydration | Office | 49 | 14 | $8.85 | $434 |
| 96417 Chemotherapy Administration | Office | 45 | 17 | $45.51 | $2,048 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 39 | 15 | $1.98 | $77.13 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 39 | 12 | $0.83 | $32.34 |
| 96375 Injection Administration | Office | 38 | 15 | $10.99 | $418 |
By year: 2022 $1.7M for 108,381 services; 2023 $1.7M for 92,799 services; 2024 $1.3M for 69,360 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 622 | 270 | $7.60 | $4,729 |
| 81002 Clinical Chemistry | 22 | 13 | $3.41 | $75.02 |
Medicare prescription drug claims, 2024
In 2024, the drug Rajni Sinha prescribed most often to Medicare patients was Anastrozole, with 381 prescriptions and refills. In total Rajni Sinha wrote 1,632 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 381 | 884 | 110 | $6,114 |
| Tamoxifen Citrate Generic | 75 | 197 | 24 | $1,472 |
| Valacyclovir Valacyclovir Hcl | 72 | 104 | 14 | $1,276 |
| Prochlorperazine Maleate Generic | 53 | 53 | 36 | $785 |
| Revlimid Lenalidomide | 49 | 49 | Under 11 | $718K |
| Exemestane Generic | 42 | 78 | Under 11 | $4,582 |
| Eliquis Apixaban | 39 | 64 | Under 11 | $36K |
| Oxycodone Hcl Generic | 32 | 32 | 13 | $597 |
| Prednisone Generic | 32 | 32 | 18 | $119 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 32 | 32 | Under 11 | $634 |
| Ondansetron Odt Ondansetron | 32 | 32 | 17 | $449 |
| Dexamethasone Generic | 30 | 34 | 22 | $524 |
| Ibrance Palbociclib | 29 | 29 | Under 11 | $461K |
| Letrozole Generic | 26 | 68 | Under 11 | $256 |
| Imbruvica Ibrutinib | 25 | 25 | Under 11 | $404K |
Brand drugs: 381 claims; generic drugs: 1,251 claims; opioid claims: 108.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajni Sinha $11K ($11K in general payments such as food, travel and fees) from 42 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $7,191.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $7,191 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $1,725 |
| Pfizer Inc. PFE | 12 | $211 |
| Abbvie Inc. ABBV | 9 | $168 |
| Genzyme Corporation SNY | 5 | $142 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $140 |
| Merck Sharp & Dohme LLC MRK | 5 | $128 |
| Array Biopharma Inc PFE | 13 | $118 |
| Eisai Inc. 4523.T | 5 | $118 |
| Daiichi Sankyo Inc. 4568.T | 5 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.